Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug 15:345:577283.
doi: 10.1016/j.jneuroim.2020.577283. Epub 2020 May 31.

Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration

Michael K Racke  1 , Scott D Newsome  2
Affiliations
Editorial

Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration

Michael K Racke et al. J Neuroimmunol. .
No abstract available

PubMed Disclaimer

References

    1. Barzegar M., Mirmosasayyeb O., Nehzat N., Sarrafi R., Khorvash F., Maghzi A.-H., Shaygannejad V. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Neurol. Neuroimmunol. Neuroinflamm. 2020;7(4):e753. - PMC - PubMed
    1. Borriello G., Ianniello A. COVID-19 occurring during natalizumab treatment: a case report in a patient with extended interval dosing approach. Mult. Scler. Relat. Disord. 2020;41:102165. (Online ahead of print) - PMC - PubMed
    1. Chiarini M., Paghera S., Moratto D., De Rossi N., Giacomelli M., Badolato R., Capra R., Imberti L. Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-Cov-2 infection. J. Neuroimmunol. 2020 (this issue) - PMC - PubMed
    1. Ebenezer D.L., Fu P., Natarajan V. Targeting sphingosine-1-phosphate signalingin lung diseases. Pharmacol. Ther. 2016;168:143–157. - PMC - PubMed
    1. Montero-Escribano P., Matias-Guiu J., Gomez-Iglesias P., Porta-Etessam J., Pytel V., Matias-Guiu J. Anti-CD20 and COVID-19in multiple sclerosis and related disorders: a case seriesof 60 patients from Madrid, Spain. Mult. Scler. Relat. Disord. 2020;42:102185. (Online ahead of print) - PMC - PubMed

Publication types

Substances